Skip to main content
ASTAL LABORATORIES LIMITED logo

ASTAL LABORATORIES LIMITED — Investor Relations & Filings

Ticker · 512600 ISIN · INE307N01014 LEI · 8945004HO2WCBQ0CJ976 BSE.NS Manufacturing
Open in API
Filings indexed 445 across all filing types
Latest filing 2020-09-02 Regulatory Filings
Country IN India
Listing BSE.NS 512600

About ASTAL LABORATORIES LIMITED

https://miel.co.in/

Astal Laboratories Limited is a pharmaceutical organization engaged in the development, manufacturing, and marketing of a diverse range of pharmaceutical formulations. The company's product portfolio encompasses various dosage forms, including tablets, capsules, liquid orals, and topical preparations. It operates across several therapeutic categories, such as anti-infectives, analgesics, and gastrointestinal treatments. Astal Laboratories prioritizes quality control and adheres to established manufacturing standards to ensure the safety and efficacy of its products. The company focuses on providing accessible healthcare solutions through a robust distribution network and a commitment to research-driven formulation development.

Recent filings

Filing Released Lang Actions
MACRO (INTERNATIONAL) EXPORTS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/09/2020 ,inter alia, to consider and approve Unaudited Financial ....
Regulatory Filings Classification · 95% confidence The document is a short notice informing the stock exchange about a scheduled Board Meeting to consider and take on record the unaudited financial results for the quarter ended June 30, 2020. It references compliance with SEBI regulations and mentions the trading window closure related to the announcement of these results. The document does not contain the actual financial results or detailed financial data but is an announcement of an upcoming event related to financial reporting. The length is only 1595 characters, indicating it is a brief notice rather than a full report. Therefore, it fits the category of a Regulatory Filing (RNS) as a general regulatory announcement rather than an Interim/Quarterly Report (IR) or Earnings Release (ER).
2020-09-02 English
Financial result for March 31,2020
Annual Report Classification · 95% confidence The document contains detailed financial statements including a statement of financial results for the quarter and year ended 31st March 2020, balance sheet data, and notes on accounting standards and audit reviews. It references audited and unaudited figures, includes comprehensive financial data, and mentions approval by the Board of Directors and review by statutory auditors. The presence of full financial statements and detailed notes indicates this is a comprehensive financial report for a full fiscal year, consistent with an Annual Report (10-K equivalent). The document is about 15,000 characters long, which is substantial and contains actual financial data, not just an announcement or certification. Therefore, the appropriate classification is Annual Report (10-K).
2020-08-13 English
MACRO (INTERNATIONAL) EXPORTS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/08/2020 ,inter alia, to consider and approve Board Meeting ....
Regulatory Filings Classification · 95% confidence The document is a formal letter addressed to the stock exchange (BSE Limited) informing about a scheduled Board Meeting to consider and take on record the Audited Financial Results for the quarter and year ended 31st March 2020. It references compliance with SEBI Listing Obligations and Disclosure Requirements Regulations, specifically Regulation 29 and 33, which pertain to disclosure of financial results. The document does not contain the financial results themselves but is an intimation or announcement of the upcoming board meeting where these results will be considered. The document length is short (1635 characters), and it serves as a notification rather than the actual financial report. According to the rules, such a document is classified as a Regulatory Filing (RNS) because it is a general regulatory announcement and does not contain substantive financial data or the report itself.
2020-08-05 English
MACRO (INTERNATIONAL) EXPORTS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/08/2020 ,inter alia, to consider and approve Postponement ....
Regulatory Filings Classification · 95% confidence The document is a letter from Macro International Limited addressed to the BSE Limited, informing about the postponement of a Board Meeting originally scheduled for 31st July 2020. The meeting was to approve the Audited Financial Results for the quarter and year ended 31st March 2020. The postponement is due to a containment zone declaration caused by the COVID-19 pandemic. The document does not contain any financial data or results itself, nor does it provide any report or detailed financial information. It is an announcement regarding a change in the schedule of a board meeting related to financial results approval. Given the short length (1487 characters) and the nature of the content (an announcement about a meeting postponement), this fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory announcements that do not fit other specific categories.
2020-08-01 English
Confirmation certificate in the matter of Regulation 74(5)
Regulatory Filings Classification · 95% confidence The document is a confirmation certificate issued by Beetal Financial & Computer Services Pvt Ltd, acting as a registrar and share transfer agent. It references compliance with Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018, and confirms the dematerialization of securities for the quarter ended June 2020. The content is a regulatory compliance confirmation letter rather than a financial report or announcement of financial results. It does not contain financial statements, management discussion, or shareholder meeting information. The document is short (1802 characters) and serves as a certification or confirmation related to regulatory requirements. According to the rules, such officer certifications or confirmations should be classified as Regulatory Filings (RNS).
2020-07-10 English
Closure of Trading Window of 30/06/2020
Regulatory Filings Classification · 95% confidence The document is a letter addressed to the stock exchange regarding the closure of the trading window due to pending approval of financial results. It references SEBI regulations on insider trading and informs about the trading window closure period related to the announcement of unaudited financial results for the quarter ended 30th June 2020. The document does not contain any financial data or results itself, nor does it present a report. It is an announcement about trading restrictions in relation to upcoming financial disclosures. The document length is short (2431 characters) and it serves as a regulatory compliance notice rather than a financial report or earnings release. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for such compliance and regulatory announcements that do not fit other categories.
2020-07-06 English

Browse filings by year

8 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.